Ranbaxy Innovation and Growth Focus slide image

Ranbaxy Innovation and Growth Focus

Shareholding Pattern Ranbaxy shareholders are primarily large institutions Fls, 8% Public, 13% GDR, 2% Others*,1% Mutual Funds, 2%- Fils, 11% Daiichi Sankyo Company, Limited, 64% Others include Non Residents and NDCO's as on 30th March, 2013 RANBAXY Trusted medicines.Healthier lives 34
View entire presentation